₹ 14.51 Cr
0.89%
Nifty Healthcare TRI
INF740KA1WC7
100.0
100.0
100
Mr. Anil Ghelani, Mr. Diipesh Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| DSP Nifty Healthcare Index Fund - Regular - Growth | - | - | - |
| NIFTY Healthcare TRI | 0.77 | 23.37 | 14.49 |
Equity
Debt
Others
The investment objective of the Scheme is to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 19.16 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 8.58 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 8.55 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.17 |
| Dr. Reddys Laboratories Ltd | 7.61 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.36 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.0 |
| FORTIS HEALTHCARE LIMITED. EQ | 4.76 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.98 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.86 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.72 |